Highest-materiality recent filing
Firsthand Technology Value Fund Q3 NAV drops to $0.04 from $0.11; net investment loss $430,629
Net assets fell to $296,547 ($0.04/share) as of Sept 30, 2025, from ~$0.7M ($0.11/share) at June 30, 2025.
Firsthand Technology Value Fund FY2024 NAV drops to $0.15; net assets $1.1M
Net assets $1.1M ($0.15/sh) vs $1.5M ($0.22/sh) at Sep 30, 2024.
Firsthand Technology Value Fund Q1 NAV drops to $0.02/share on $3M Revasum write-down
Net assets fell to $0.2M ($0.02/share) from $1.3M ($0.18/share) at Dec 31, 2023.
Firsthand Technology Value Fund reports FY2023 NAV of $0.18/share, down from $4.44
Net assets fell to $1.3M from $30.6M; NAV per share dropped to $0.18 from $4.44.
Firsthand Technology Value Fund launches strategic review with Ladenburg Thalmann
Board engaged Ladenburg Thalmann to evaluate strategic options, including merger, sale, or restructuring.
Firsthand Tech Value Fund NAV plunges to $0.10 from $1.61; major losses from two holdings
Net assets fell to $0.7M ($0.10/share) at Sep 30, 2023, vs $11.1M ($1.61/share) at Jun 30, 2023.
Firsthand Technology Value Fund delisted from Nasdaq; begins trading on OTCQB
Received Nasdaq notice July 28, 2023, for failing to maintain $5M minimum market value of publicly held shares.
Board approved seeking stockholder approval to withdraw BDC election and pursue liquidation of the Fund.
Firsthand Technology Value Fund voluntarily delists from Nasdaq, citing non-compliance and costs
SVVC notified Nasdaq on Oct 6, 2023 to voluntarily delist; Form 25 to be filed Oct 16; delisting effective ~Oct 26.
Firsthand Technology Value Fund Q2 NAV falls 57% to $1.61 per share; net loss $14.8M
Net assets $11.1M ($1.61/share) vs $25.9M ($3.75/share) at Mar 31, 2023.
On July 28, 2023, Nasdaq notified Firsthand that its market value of publicly held shares fell below $5,000,000.
Firsthand Technology Value Fund reports Q1 NAV $3.75, down 16% from Q4 2022
Net assets $25.9M ($3.75/share) vs $30.6M ($4.44/share) at Dec 31, 2022.
Firsthand Technology Value Fund reports preliminary NAV of $3.75 as of March 31, 2023
Preliminary NAV $3.75 per share as of March 31, 2023.
Preliminary NAV $4.10 per share as of March 31, 2023; cash $0.12/share.
Firsthand Technology Value Fund receives Nasdaq deficiency notice for bid price below $1 for 30 days
Received Nasdaq deficiency notice on April 27, 2023 for closing bid price below $1.00 for 30 consecutive business days.
Firsthand Tech Value Fund NAV drops to $4.44 from $13.75; net loss $64.1M for FY 2022
Net assets $30.6M ($4.44/share) vs $94.8M ($13.75/share) a year earlier.
Firsthand Technology Value Fund discloses top holdings: 95.9% in top five, IntraOp Medical 44.2%
Top five holdings as of Nov 30, 2022: IntraOp Medical 44.2%, Wrightspeed 26.1%, Hera Systems 15.5%, Revasum 7.6%, EQX Capital 2.6%.
Firsthand Tech Value Fund discloses top 5 holdings = 95.4% of $46.8M estimated investments
Top 5 holdings as of Oct 31: IntraOp (44.3%), Wrightspeed (25.8%), Hera (15.6%), Revasum (7.1%), EQX (2.6%).
Q3 NAV drops to $5.58 from $7.22; net investment loss of $8.8M
Net assets $38.4M ($5.58/share) vs $49.8M ($7.22/share) at June 30, 2022.
Preliminary NAV of $5.58 per share as of September 30, 2022.
Firsthand portfolio company Hera Systems wins U.S. Space Force Tetra-5 contract up to $44.5M
Hera Systems, a holding since 2015, selected to provide spacecraft and software for Tetra-5 program.
Net assets fell to $49.8M ($7.22/share) from $87.4M ($12.68/share) as of March 31, 2022.
Firsthand Tech Value Fund: top 5 holdings = 92.4% of $66.8M portfolio as of May 31
Top holdings: IntraOp Medical (32.2%), Wrightspeed (28.5%), Revasum (17.5%), Hera Systems (9.4%), Pivotal Systems (4.9%).
Firsthand Technology Value Fund's top 5 holdings equal 95.5% of portfolio as of April 30, 2022
Top five: IntraOp Medical (29.7%), Revasum (26.8%), Wrightspeed (25.7%), Hera Systems (8.5%), Pivotal Systems (4.8%).
Preliminary NAV of $12.68 per share as of March 31, 2022; total investments $82.2M.
Firsthand Technology Value Fund: 95.5% of assets in top 5 holdings as of Feb 2022
Top holdings: IntraOp Medical (29.4%), Revasum (29.2%), Wrightspeed (25.2%), Hera Systems (6.1%), Pivotal Systems (5.7%).
NAV per share $13.75 as of Dec 31, 2021, down from $14.82 a year earlier.
Firsthand Technology Value Fund discloses top 5 holdings: 95.3% of investments in 5 firms
Top five holdings as of Jan 31, 2022: Revasum (32.8%), IntraOp Medical (27.1%), Wrightspeed (23.2%), Pivotal Systems (6.8%), Hera Systems (5.5%).
Preliminary NAV per share $13.75 as of Dec 31, 2021; total investments $91.1M ($13.22/share).
On September 22, 2023, Rodney Yee resigned as a member of the Board of Directors of Firsthand Technology Value Fund, Inc.
appointed Kevin Landis, the current Chairman of the Board of Directors, and President and Chief Executive Officer of the Company to serve as the Company’s Chief Financial Officer, also effective on August 30, 2023.
On August 30, 2023, Omar Billawala resigned as the Chief Financial Officer of Firsthand Technology Value Fund, Inc. (the “Company”), effective on that date.
On August 14, 2023, Nicholas Petredis resigned as a member of the Board of Directors of Firsthand Technology Value Fund, Inc. (the “Fund”) for health and medical reasons.
Max materiality 0.85 · Median 0.60 · Most common event other_material